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Abstract 27 
A co-polarization scheme for [1,4-13C2]fumarate and [1-13C]pyruvate is presented to 28 
simultaneously assess necrosis and metabolism in rats with hyperpolarized 13C MR. The 29 
co-polarization was performed in a SPINlab polarizer. In addition, the feasibility of 30 
simultaneous PET and MR of small animals with a clinical PET/MR is demonstrated. The 31 
hyperpolarized metabolic MR and PET is demonstrated in a rat model of necrosis. 32 
The polarization and T1 of the co-polarized [1,4-13C2]fumarate and [1-13C]pyruvate 33 
substrates were measured in vitro and compared to those obtained when the substrates 34 
were polarized individually. A polarization of 36±4 % for fumarate and 37±6% for pyruvate 35 
was obtained. We found no significant difference in the polarization and T1 values 36 
between the dual and single substrate polarization. 37 
Rats weighing about 400 g were injected i.m. in one of the hind legs with 200 μL of 38 
turpentine to induce necrosis. Two hours later, 13C metabolic maps were obtained with a 39 
Chemical Shift Imaging sequence (16x16) with a resolution of 3.1x5.0x25.0 mm3. The 13C 40 
spectroscopic images were acquired in 12 s, followed by an 8 min 18F-FDG PET 41 
acquisition of 3.5 mm resolution. [1,4-13C2]malate was observed from the tissue injected 42 
with turpentine indicating necrosis. Normal [1-13C]pyruvate metabolism and 18F-FDG 43 
uptake were observed from the same tissue. 44 
The proposed co-polarization scheme provides a means to utilize multiple imaging 45 
agents simultaneously, and thus to probe various metabolic pathways in a single 46 
examination. Moreover, it demonstrates the feasibility of small animal research on a 47 
clinical PET/MR scanner for combined PET and hyperpolarized metabolic MR. 48 
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Introduction 49 
Since the introduction of the dissolution Dynamic Nuclear Polarization (dDNP) technique1 50 
to enhance the 13C signal in applications like magnetic resonance spectroscopic imaging 51 
(MRSI), the metabolic fluxes of hyperpolarized 13C substrates have shown great potential 52 
to improve the detection and characterization of many pathologies, especially cancer. For 53 
instance, studies have indicated that the lactate signal 2-4, and in some cancer types the 54 
alanine signal 5, are higher in cancer than in normal tissue, after the administration of 55 
hyperpolarized [1-13C]pyruvate. This observation is referred to as the Warburg effect and 56 
it is due to the fact that most cancer cells have elevated glycolysis even in the presence 57 
of sufficient oxygen. Moreover, MR imaging with hyperpolarized [1,4-13C2]fumarate was 58 
shown to allow early detection of necrosis 6-8. The conversion of fumarate into malate is 59 
a normal step in the mitochondrial tricarboxylic acid cycle and is catalyzed by fumarase. 60 
As the enzyme is not present in the extracellular space, but exposed by cells that undergo 61 
necrosis, it is demonstrated that the observation of an increased [1,4-13C2]malate 62 
production, after intravenous administration of hyperpolarized [1,4-13C2]fumarate, can be 63 
used as a marker of necrosis.  64 
In order for the DNP process to be effective, it is important to comply with certain 65 
requirements during sample preparation and polarization. First of all, the 13C labeled 66 
substrates must be in an amorphous (glassy) solid state with the appropriate electron 67 
paramagnetic agent uniformly distributed, such that an efficient coupling between electron 68 
spin and nuclear spins is achieved in the solid state 1,9,10. Fumaric acid (FA) dissolved in 69 
dimethyl sulfoxide, for instance, requires rapid freezing to achieve this amorphous solid 70 
state and to prevent the FA crystallization, which can significantly reduce the nuclear spin 71 
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polarization. Pyruvic acid (PA), on the other hand, is a liquid at room temperature that 72 
glasses well without additives. Moreover, the concentration of the desired agents, 73 
solvent/glassing agents and the concentration and type of free radical must all be 74 
optimized to achieve optimal polarization for the 13C substrates. In addition, appropriate 75 
dissolution medium (DM) and neutralizing medium (NM) must be prepared for each agent 76 
in order to ensure physiological pH and osmolarity/tonicity for in vivo use. 77 
The spectrum obtained following the in vivo infusion of a hyperpolarized 13C material is 78 
often sparse. In some cases, this sparsity can be exploited to combine more than one 13C 79 
agent during the hyperpolarization and imaging. This way multiple enzymatic pathways 80 
can be probed simultaneously. Previous attempts of multi-agent polarization have been 81 
performed with the Hypersense (Oxford Instruments, UK) polarizer 11-14. This study 82 
presents a co-polarization scheme for [1,4-13C2]fumarate and [1-13C]pyruvate to 83 
simultaneously assess necrosis and metabolism. The co-polarization presented in this 84 
work is performed in a SPINlab polarizer (GE Healthcare) 15,16. Although the SPINlab 85 
benefits from relatively higher magnetic field and lower temperature, which result in high 86 
polarization, the polarization build-up durations are considerably longer (2~4 hours). The 87 
SPINlab overcomes this in part by having four samples in parallel; however, the adoption 88 
of multi-substrate polarization scheme makes the polarization in SPINlab more appealing. 89 
The polarization and T1 of the co-polarized [1,4-13C2]fumarate and [1-13C]pyruvate were 90 
measured in phantoms and compared to those obtained when the substrates were 91 
polarized individually. In vivo experiments were conducted in rats with induced necrosis 92 
via the injection of 200 μL of turpentine at the deep muscle of the left hind leg. 13C 93 
metabolic maps were obtained to assess the cellular uptake and the conversion of [1-94 
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13C]pyruvate into [1-13C]lactate and to assess the conversion of [1,4-13C2]fumarate into 95 
[1,4-13C2]malate. In addition, 18F-fluorodeoxyglucose (18F-FDG) Positron Emission 96 
Tomography (PET) images were acquired simultaneously with the 13C MRSI.   97 
Experimental 98 
Sample preparation 99 
For pyruvate preparation, AH111501 trityl radical (GE Healthcare, Denmark) was added 100 
to a sample of [1-13C]pyruvic acid (PA) (14 M) (Sigma Aldrich, Denmark) to a final 101 
concentration of 15 mM. The fumarate was prepared by dissolving [1,4-13C2]fumaric acid 102 
(FA) (Cambridge Isotope Laboratories, MA, USA) in dimethyl sulfoxide (DMSO) (Sigma 103 
Aldrich, Denmark). Sonication and vortex mixing were used until all the FA crystals had 104 
dissolved. AH111051 radical was then added and dissolved in the solution. To optimize 105 
the formulation of FA, three different batches were prepared with FA/radical 106 
concentrations of 3.6 M/8 mM, 3.6 M/12 mM and 2.8 M/15 mM, respectively.  107 
The polarizer and fluid path assembly  108 
The co-polarization was made in a SPINlab polarizer (GE Healthcare, Denmark). Figure 109 
1-a shows the fluid path assembly designed for use with the SPINlab. The fluid path 110 
consists of a vial (1) containing the sample and connected to the dissolution syringe (2) 111 
via two concentric tubes (3). The tubes can be pushed into the polarizer through the 112 
dynamic seal (4) without compromising the vacuum. The syringe has an exit port (5) that 113 
connects to a tube for transfer of the hyperpolarized solution. 114 
  
6 
 
The regular sample preparation procedure for the SPINlab fluid path requires that the vial, 115 
after adding the 13C substrate, is frozen in liquid nitrogen (LN2). This freezing is necessary 116 
to perform pressure check and helium purging. Helium purging is needed to have a helium 117 
exchange gas inside the fluid path when the vial is cooled to <1 K. 118 
The regular procedure to load the sample into the SPINlab involves lowering the sample 119 
vial into the sample pot (see Figure 1-c), were the hyperpolarization take place, through 120 
multiple steps (gradual insertion over 15 min) to avoid excessive increase in the helium 121 
temperature. This multi-steps lowering process was found to result in FA crystallization. 122 
Therefore, to avoid the FA crystallization, the sample preparation and loading was 123 
modified as detailed in the next section. 124 
Co-polarization of FA and PA 125 
The fluid path was prepared by first placing 25 μL (around 350 μmol) of PA in the sample 126 
vial and then freezing it in LN2. 100 μL (about 350 μmol) of FA was then added on top of 127 
the PA and the vial was placed in LN2 again (see Figure 1-b). The vial is then glued to the 128 
tube set with the tip immersed in LN2 and the neck above the liquid surface. The rest of 129 
the fluid path preparations (pressure check and He purging) were done according to the 130 
manufactures instructions. After the preparation, the fluid path was placed in the SPINlab 131 
and the vial containing the two compounds was initially placed at the airlock for 20 to 30 132 
min, thus allowing the substrates to thaw before lowering the sample vial into the helium 133 
pot. During the melting period, it is assumed that the difference in density prevents the 134 
mixing of the two substrates. The densities of PA and FA solutions are 1.3 g/mL and 1.2 135 
g/mL, respectively. Then the sample vial was directly lowered into the helium bath in either 136 
one (A: directly to the sample pot) or two steps (B: directly to the sample pot and then 137 
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retracted to the 4 K thermal link for 10 min), instead of the normal scheme of going through 138 
a multi-step lowering process, to avoid the crystallization of the FA in the sample.  139 
For both in vivo and in vitro studies, the sample was irradiated with microwaves at 140 
139.64 GHz and 40 mW (the two samples have the same optimal microwave frequency). 141 
The sample was polarized for at least 4 h in the in vitro phantom studies to measure the 142 
liquid-state polarization. Before dissolving the samples, it was ensured that the 143 
polarization curve in the SPINlab reached the flat plateau. In the in vivo animal 144 
experiments the samples were polarized for about 3 h, i.e. after reaching more than 90% 145 
of maximum. The polarization curve was fitted with a single exponential.  146 
The dissolution syringe was filled with about 15 g of a DM (water for injection with 0.1 g/L 147 
ethylenediaminetetraacetic acid disodium salt dehydrate). The dissolved sample was 148 
mixed with 0.95 g of NM (water for injection with 0.72 M NaOH, 0.4 M 2-Amino-2-149 
(hydroxymethyl)-1,3-propanediol and 0.1 g/L ethylenediaminetetraacetic acid disodium 150 
salt dehydrate).  151 
Some of the dissolved samples were used after the in vitro study to measure the 152 
concentration of the two substrates. The concertation was measured by quantitative NMR 153 
using a 400 MHz spectrometer (DirectDrive, Agilent) and a 100 mM 13C-urea reference.  154 
Single substrate polarization 155 
In addition to the dual polarization of FA and PA, the FA was polarized separately. This 156 
was to investigate if there are differences in T1 and polarization values between the single 157 
and dual substrate polarization. The single FA polarization and dissolution was made in 158 
the same manner as described in the previous section for the dual substrate. About 350 159 
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μmol (100 μL) of FA sample was loaded in the vial and dissolved with 15 g of DM and 160 
0.65 g of NM. 161 
Phantom MR experiments for polarization and T1 measurements 162 
All imaging was performed in a clinical 3T PET/MR scanner (Siemens mMR Biograph, 163 
Siemens, Erlangen, Germany). A dual-tuned transmit/receive flex surface coil (RAPID 164 
Biomedical) was used for both 1H and 13C acquisition. The coil consists of a 110 mm loop 165 
for 13C and a 180 mm x 244 mm butterfly for 1H. The 90° flip angle was calibrated from a 166 
13C-urea phantom at approximately the position of the rat. Phantoms and rats were placed 167 
in the center of the 11 cm loop coil. 168 
About 5 mL of the polarized material was injected into a previously shimmed phantom 169 
tube, approximately 30 s after the dissolution. 180 13C spectra were acquired without 170 
spatial encoding using an excitation pulse with 5 flip angle (315 us pulse duration) and 171 
repetition time TR of 5 s. The sampling spectral window was set to 6000 Hz with 512 172 
spectral points.  173 
For each spectrum of the dynamic acquisition, the signal integrals were calculated after 174 
baseline correction. A mono-exponential decay function, equation 1, was fitted for each 175 
of the two substrate signals to obtain the relaxation time, T1, and the initial longitudinal 176 
magnetization, ܯூ.  177 
ܵሺ݊ሻܯூ	ݏ݅݊ሺߙሻ	cos௡ሺߙሻ	݁ି௡
்ோ
்ଵ																		ሺ1ሻ, 178 
where ܵሺ݊ሻ is the signal recorded after the ݊th excitations, ܴܶ is the repetition time, and 179 
ߙ is the flip angle.  180 
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A 13C-urea phantom (4 M) was placed next to the tube with the hyperpolarized solution 181 
and was used to calibrate the 90o flip angle and as a reference to measure the 182 
polarization. To quantify the polarization, the initial signal of the hyperpolarized sample 183 
was compared to the urea signal and corrected for the concentration difference. 184 
In vivo rat experiment 185 
Animal handling and experimental procedures were performed according to the 186 
guidelines from Danish Animal Experiments Inspectorate (permit no. 2011/561−14). The 187 
in vivo study was conducted in two rats weighing (400 g). The first rat was only injected 188 
with hyperpolarized FA. The second rat received two injections separated by 10 min. The 189 
first injection was only hyperpolarized FA, and the second injection was dual polarized 190 
FA and PA. Necrosis was induced by intramuscular injection of 200 μL of sterile turpentine 191 
oil in one of the hind legs. This was followed by subcutaneous injection of 400 μL of 192 
Buprenorphine (TEMGESIC, 0.03 mg/mL) to control the acute paint from the turpentine 193 
injection. Two hours later, the animal was transferred to the PET/MR scanner to acquire 194 
13C MRS and PET images. 195 
During the MR scanning, the animals were anaesthetized with 3% Sevoflurane mixed in 196 
O2. A catheter was inserted in the tail vein for the administration of the hyperpolarized 197 
mixture of pyruvate and fumarate or fumarate alone. 2 mL (0.14 mmol/kg) of the co-198 
polarized substrates was injected in the rat. This injection was done approximately 20 s 199 
after dissolution, during this period the co-polarized material was transferred to the MRI 200 
room from the SPINlab in a syringe that was then connected to the tail vein catheter. The 201 
hyperpolarized substrate was injected manually over a period of 10 s. 202 
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Anatomical long axis proton MR images were acquired prior to the 13C MRS scans for 203 
spatial localization of the necrotic tissue within muscle. Chemical shift images (CSI) (with 204 
FA=10, TR= 80 ms, TE = 1.4 ms, FOV = 50 x 80 mm2, matrix=16x16, nominal in-plane 205 
resolution 3.1 x 5 mm2, slice thickness = 25 mm) were acquired 20 s after the end of 206 
administration of the hyperpolarised [1-13C]pyruvate and  [1,4-13C2]fumarate mixture.  207 
One hour before the PET/MR imaging session, the rats were intravenously injected with 208 
80 MBq of 18F-FDG. An 8 min PET scan (3.5 mm isotropic resolution) was acquired during 209 
the acquisition of the MR images. Dixon imaging was used to obtain fat and water maps 210 
that were used to correct for the attenuation in the PET images. 211 
The acquired free induction decay signal at each voxel of the CSI data was first zero-filled 212 
by a factor two to increase the spectral resolution, and the signal was then apodized using 213 
an exponential function, ݁ି௙.௧ with ݂ ൌ 15	Hz. Metabolic maps were generated for each 214 
metabolite from the peak amplitude in the real phased spectra after baseline correction 215 
and fitting with a generalized linear model. The metabolic maps were resampled to the 216 
same resolution of the anatomical proton images, 0.4x0.4 mm2, and registered onto them. 217 
Thresholding was applied to remove the noise level. The metabolite maps were 218 
normalized with respect to the standard deviation of the noise, which was estimated from 219 
a background region outside of the animal.  220 
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Results 221 
Polarization of [1,4-13C2]fumarate and [1-13C]pyruvate 222 
Figure 2 shows representative polarization build-up and the temperature curves recorded 223 
at the equilibrator and sample pot for the multi-step lowering process, typically used for 224 
PA, and the two-step lowering process, used for samples containing FA. The efficiency 225 
of the multi-step lowering process in minimizing the temperature variation at the sample 226 
pot is evident.  227 
The polarization of samples containing 600 mg of FA from the three different batches 228 
(with FA/AH111051 concentrations of 2.8M/15mM, 3.6M/8mM and 3.6M/12mM) resulted 229 
in build-up time constants and final solid-state polarization values detailed in Table 1, for 230 
one and two insertion steps. The batches showed high variation in build-up time constant 231 
and less variation in the saturation level. The batch with 3.6M/12mM FA/AH111051 232 
concentration had the shortest build-up time constant. This batch also showed no 233 
significant difference between the one (A) and two (B) lowering steps in the final saturation 234 
level, but the build-up time constant was shorter for (A) ; however, the one-step lowering 235 
can result in a higher increase in the sample pot temperature. The final solid state 236 
polarization values for these batches were comparable. The solid state NMR signals may 237 
vary significantly between measurements due to the uncontrolled position of the sample 238 
within the NMR coil that is dimensioned to hold up to four samples. However, the 239 
comparison is based on the liquid state polarization obtained post dissolution.  240 
Table 1 also shows the liquid state polarization measurements obtained for the three 241 
formulations of fumarate via dynamic acquisition of 13C spectra in the PET/MR scanner 242 
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30 s after dissolution. There was no difference between the batches in the measured 243 
polarization. Since all the batches gave similar polarization results, the subsequent 244 
experiments were conducted with the 3.6M/12mM FA/AH111051 batch. This batch gives 245 
higher concentration of fumarate, which results in higher MR signal. In addition, this batch 246 
had relatively faster polarization build-up.  247 
The results of the experiment to determine whether there is a difference in the polarization 248 
and T1 values between the dual and single substrate polarization is summarized in Table 249 
2. No significant difference was found in the measured values of polarization of FA for 250 
single and dual FA/PA polarization. The polarization level of PA, 37%, obtained with the 251 
dual polarization scheme agrees with the polarization values found in the literature 17.  252 
After the dissolution of the polarized materials in the (15 g) DM and (0.95 g) NM, the 253 
measured concentrations of fumarate and pyruvate were about 31±2 mM (n=2). The 254 
measured pH value was 7.7±0.3 (n=8). The volume of the sample received after 255 
dissolution was 6±1 mL (n=3). The remaining volume was retained in the fluid path during 256 
the dissolution as dead volume. 257 
Animal experiment 258 
Figure 3 shows the expected position of the metabolite peaks. The spectrum is sparse 259 
enough to allow clear quantification the injected substrates and their products. Figure 4 260 
shows the anatomical image and the 13C spectrum at the necrotic tissue for the rat that 261 
was injected with only hyperpolarized fumarate. The maps of fumarate and malate 262 
distributions within a slice covering the necrotic region, in addition to FDG-PET, are also 263 
shown in Figure 4. Figure 5, shows the anatomical image and the 13C spectrum at the 264 
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necrotic tissue for the rat that received the dually hyperpolarized fumarate and pyruvate. 265 
Clear malate signal was visible at the necrotic site with both the single fumarate and dual 266 
pyruvate/fumarate injections and no malate signal was observed elsewhere.  Figure 5 267 
also shows the PET images acquired for the same animal during the same MR imaging 268 
session. The FDG uptake by the different organs is represented using maximum intensity 269 
projection. An increase in the signal from lactate and from other pyruvate products was 270 
observed at the necrotic tissue. There is no clear effect from the necrosis on the FDG-271 
PET signature. 272 
Discussion  273 
The main aim of this study was to investigate the technical feasibility of a method to 274 
simultaneously polarize a low dose of FA and PA in a SPINlab polarizer, and to image 275 
their metabolism in small animals with a clinical MR scanner. This setup provides a mean 276 
to utilize multiple imaging agents at once, and thus to probe various physiological 277 
characteristics and obtain valuable biological data, in a single examination. Secondly, it 278 
enables small animal research on a typical clinical scanner setup. Increased conversion 279 
of pyruvate into lactate, also known as the Warburg effect, is a main hallmark of neoplastic 280 
activity 18 and has the potential to effectively monitor the response to treatment 19. The 281 
production of malate from fumarate has been proposed as sign for necrosis 6,8,20, and it 282 
is expected that the degree of necrosis induced by treatment, is proportional to the 283 
amount of malate produced. The amount of malate observed in the 13C spectrum depends 284 
also on the time of imaging following the intervention as seen in the difference in malate 285 
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signal between the two injections in rat two. This is because the fumarase is washed out 286 
of the tissue within a few hours to the blood plasma and then to the urine 21.  287 
High lactate signal, and also high signal from other pyruvate products like alanine and 288 
bicarbonate, was also observed at the necrotic muscle tissue in the in vivo experiment 289 
with dual FA and PA injection. The increased signal from pyruvate products is not 290 
unexpected, since intracellular enzymes like LDH also escape to the extracellular space 291 
when the cellular membranes are broken 22. This is important to bear in mind, since many 292 
types of therapies induce necrosis in cancer tissue, which may result in elevated lactate 293 
production after injection of hyperpolarized pyruvate. Moreover, there is also evidence 294 
that cancer cells that survive the treatment, can benefit from the inflammatory response 295 
that follows, since it promote proliferation by providing the tumor environment with growth 296 
factors, survival factors and proangiogenic factors 23,24. Therefore, simultaneous 297 
assessment of metabolism and necrosis with the setup proposed here can give a more 298 
complete picture, and allow distinguishing whether the high lactate signal is because the 299 
necrosis process from therapy is taking effect or because the tumor is thriving. Another 300 
factor contributing to the higher signal from pyruvate and its metabolites in this model, 301 
could be a higher cellular uptake of pyruvate. In any case, the appearance of the malate 302 
signal is a much more sensitive marker of necrosis than a small change in the large lactate 303 
signal. 304 
Acquiring PET images at the same time as 13C hyperpolarized MR imaging adds 305 
additional molecular imaging characterization, and allows comparing PET tracers with 306 
their analogous MR counterparts. For instance, although 18F-FDG, unlike [1-13C]pyruvate,  307 
does not show the actual metabolic reactions, the concentrations of 18F-FDG in the PET 308 
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images reflects regional uptake of glucose. Thus, FDG-PET also reflects tissues with high 309 
metabolic activity, and the two markers, 18F-FDG and 13C-pyruvate, can be 310 
complementary 25,26. The lactate signal was clearly detectable at various tissues from the 311 
13C spectra of the CSI whereas the malate signal was confined to necrotic tissue. There 312 
was no change in the FDG uptake or the lactate signal. 313 
We were able to demonstrate the feasibility of using a state-of-the-art clinical PET/MR 314 
scanner for in vivo imaging of rats. Good image quality that allows the evaluation of 315 
metabolic activities in various tissues was achievable with both PET and 13C-MRS 316 
imaging. In this study, the in-plane resolution used with CSI was 3.1 x 5 mm2, but finer 317 
spatial resolution can be achieved. The minimal in-plane resolution for the CSI allowed 318 
on our system is 3.1 mm with nominal gradient strength, which is the maximum value that 319 
the manufacturer recommends for reliable performance. However, in theory, a resolution 320 
as fine as 1.5 mm can be achieved with the maximum gradient strength that can be 321 
realized by the scanner. This is because, the CSI sequence does not require very strong 322 
gradients, unlike other faster spectroscopic sequences, such as Echo Planar 323 
Spectroscopic Imaging (EPSI), which can be very demanding on gradient strength and 324 
slew rate. The maximum gradient strengths and slew rate on the Siemens mMR Biograph 325 
are 42 mT/m and 180 mT/m/ms, respectively. These are significantly lower compared to 326 
1,000 mT/m gradient strength and 5,000 mT/m/ms slew rates on some of the state-of-327 
the-art animal scanners.  328 
One of the major problems that faced previous attempts of multi substrate polarization 329 
was the limited sample volume that can be polarized stably and dissolved successfully in 330 
the Hypersense polarizer (Oxfords, Instruments, UK), which is used in these co-331 
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polarization attempts. The limited sample volume that can be used in the Hypersense 332 
subsequently results in relatively smaller concentrations of the co-polarized substrates in 333 
the final volume (13).  SPINlab on the other hand is designed to efficiently polarize and 334 
dissolve larger substrate volumes (up to 2 g). 335 
Relatively high polarization was achieved for both FA and PA (more than 30%) when they 336 
were polarized simultaneously in the SPINlab. In addition, there was no significant 337 
difference in the polarization and T1 measurement compared to when the two substrates 338 
were polarized separately. The final concentration of the two agents after dissolution was 339 
acceptable for in vivo experiments (30 mM). This concentration however can be increased 340 
by increasing the initial volume of PA and FA in the sample vial, but will be at the expense 341 
of a larger waste. The dissolution volume can also be lowered for higher final 342 
concentration of PA and FA. The minimal effective dissolution volume that can be reliably 343 
used on the SPINlab is approximately 5-7 mL. 344 
Using multiple 13C substrates, however, brings additional burden to resolve multiple peaks 345 
in the frequency spectrum with the possibility of overlap between peaks; an issue which 346 
is less common in hyperpolarized 13C MRS compared to 1H MRS. Higher magnetic fields 347 
are more suitable for such tasks, since they give larger spacing between the peaks.  348 
Fortunately, the malate doublet was quantifiable in both single fumarate and dual 349 
fumarate/pyruvate scheme. There is also the problem of the difference in the optimal 350 
microwave irradiation frequencies for the different 13C substrates, which can limit the solid 351 
state polarization for some of them. In our case, both FA and PA had the same optimal 352 
microwave frequency. 353 
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Necrosis has been shown to play an important role in many pathological processes like 354 
central nervous system and neurodegenerative disorders 27,28, ischemia/reperfusion 355 
injuries 21, viral and microbial infections 29,30. Necrosis may also play an important role in 356 
physiological processes like ovulation 31 and embryogenesis 32. In addition, many 357 
chemotherapeutical agents used for cancer treatment are known to induce cancer cell 358 
death through necrosis 6. MRS of hyperpolarized [1,4-13C2]fumarate can play an important 359 
role in studying necrosis in vivo in these processes. The model presented here, turpentine 360 
injection into living tissue, provides a robust and easy to control technical validation 361 
method that causes necrosis and inflammatory response, and therefore can be useful in 362 
studying cellular death via necrosis. Turpentine is a mixture of alkylated aromatic 363 
hydrocarbons designed to dissolve fat, and thus they can effectively cause lipid 364 
dissolution.  365 
In conclusion, we have demonstrated the feasibility of probing the dual enzymatic 366 
pathways of [1-13C]pyruvate and [1,4-13C2]fumarate in a clinical dual PET/MR system. 367 
The in vitro measurements showed that the polarization values achieved for two 368 
substrates when polarized together, were comparable to the values obtained when each 369 
substrate was polarized individually. The experimental setup can be useful to investigate 370 
the ability of various hyperpolarized 13C substrates and PET tracers, like 18F-FDG, 371 
malate/fumarate ratio and lactate/pyruvate ratio in monitoring the response of cancer to 372 
treatment. The setup also can be used to investigate the correlation between the 373 
analogous PET and 13C MRS markers. Moreover, clinical PET/MR scanners, that are 374 
becoming widely available, could contribute not only to human clinical routine 375 
examinations, but also to biomedical researches in small animals. 376 
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Figure legends 500 
Figure 1 501 
(a) The fluid path that goes into the SPINlab. The fluid path consists of a syringe that 502 
contains the DM and sample vial that contains the 13C substrate to be polarized. The two 503 
are connected by two concentric tubes. During the dissolution the DM is transferred 504 
through the inner tube to the sample vial, where it dissolves the hyperpolarized substrate. 505 
The dissolved material flows back through the outer tube lumen toward the syringe and 506 
out of the SPINlab via the exit tube. (b) shows schematic draw of the sample vial. The 507 
vial is prepared by first adding the PA and then freezing it in LN2 and then adding the FA. 508 
The vial is then kept in LN2 during the rest of preparation of the fluid path to attain two 509 
separate layers in the vial. (c) shows the path of the vial once it is inserted in the SPINlab. 510 
The vial is initially placed in the airlock for 20 min to allow the sample to melt. Then, it is 511 
lowered in multiple steps, back and forth, along the path, to avoid excessive increase in 512 
temperature at the sample pot until it settles at the sample pot. 513 
Figure 2 514 
Typical polarization curve (shown with solid lines) starting from time = 0. The dashed and 515 
dash-dotted curves in the figure shows the temperature recorded at two positions in the 516 
SPINlab, which are the sample pot and the equilibrator, respectively. Before the start of 517 
the polarization build-up is the period during which the lowering process takes place. In 518 
(a) where multi-steps lowering is used, the variation in temperature at the equilibrator 519 
level is smaller compared with (b) where only two lowering steps were used. At the sample 520 
pot, the temperature stays almost constant for multi-steps lowering, while for the two-step 521 
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lowering there is a rise in temperature for some time (about 25 minutes) before the 522 
temperature settles at 0.8 K. 523 
Figure 3 524 
The expected positions of the peaks of interest following the administration of FA and PA. 525 
The figure illustrates that the 13C spectrum is sparse allowing co-polarization and 526 
simultaneous imaging of [1,4-13C2]fumarate and [1-13C]pyruvate.  527 
Figure 4 528 
The anatomical axial image of the first rat (a) acquired at the location of the necrotic 529 
tissue. The image was acquired with turbo spin echo (TR= 5.7 s, TE= 84 ms, echo train 530 
length of 18, number of phase encoding steps 234, Number of averages of 5, final matrix 531 
size of 256x256 covering a FOV of 100 mm x 100 mm with slice thickness of 2 mm). (b) 532 
shows the spectrum at the necrotic tissue with the fumarate peak and the malate doublet. 533 
Clear malate signal can be observed in the spectrum. The small peak at the right of the 534 
spectrum at 165 ppm is due to fold over of the 13C-urea phantom. (c) and (d) shows the 535 
metabolic maps of fumarate and malate, respectively. Notice that the malate production 536 
is confined to the necrotic region. (e) shows an axial slice with 12 mm thickness (sum of 537 
6 adjacent slices) with the FDG uptake in a plane containing the necrotic tissue. 538 
Figure 5 539 
The anatomical axial image of the second rat (a) acquired at the location of the necrotic 540 
tissue. The proton image was acquired similar to Figure 4-a. A coronal maximum intensity 541 
projection image which shows the FDG uptake by the different organs is illustrated in (b). 542 
(c) shows an axial slice with 12 mm thickness (sum of 6 adjacent slices) with the FDG 543 
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uptake in a plane containing the necrotic tissue. (d) and (e) show the phased real part 544 
spectra at the necrotic tissue, the blue box in (a), acquired for single injection of FA and 545 
dual injection of FA and PA, respectively. The malate signal can be seen in both spectra. 546 
In dual FA and PA experiment additional peaks are observed for lactate, alanine, 547 
pyruvate-hydrate and bicarbonate. Some ringing due to truncation is observed (80 ms 548 
acquisition time with apodization) (f to i) shows the metabolic maps of pyruvate, lactate, 549 
fumarate and malate, respectively. 550 
  551 
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Tables 553 
Table 1: Solid state DNP build-up data for three different samples with two different 554 
loading profiles 555 
Concentrations 
(FA/AH111501) 2.8 M/15 mM 3.6 M/8 mM 3.6 M/12 mM 
No. insertion steps ONE TWO ONE TWO ONE TWO 
Build-up time constant 
(s) 9448 5913 6718 6765 2725 3659 
S(t=∞) (a.u.) 1311 1054 740 1140 969 993 
Liquid-state 
polarization(%) 39 38 37 
 556 
Table 2: Liquid state polarization and T1 measurements for the sample with FA (3.6 M) 557 
with 8 mM of AH111501 radical 558 
n=5 Fumarate Pyruvate
 Dual Single Dual 
T1 (s) 57±2 58±2 70±3 
Polarization 
(%) 35±5 37±6 37±6 
 559 
  560 
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